Yardley Recaps Breast Cancer Data From ASCO 2018 - OncLive

OncLive
Yardley Recaps Breast Cancer Data From ASCO 2018
OncLive
The de-escalation of therapy has been a continuing theme in much of the breast cancer treatment landscape over the last year. Multiple trials from the 2018 ASCO Annual Meeting addressed this, as well as provided options for physicians who want to move ...